# Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

> **NCT03117946** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 220 (estimated)

## Conditions studied

- Lung Cancer
- Head and Neck Cancer

## Interventions

- **OTHER:** Biological samples

## Key facts

- **NCT ID:** NCT03117946
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-05-29
- **Primary completion:** 2026-08-29
- **Final completion:** 2026-11-29
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117946, "Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03117946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*